Related Experiment Video

Updated: May 13, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

MAVS: a new weapon in the fight against viral infections

Jose A Boga1, Maria de Oña, Santiago Melon

  • 1Servicio de Microbiologia, Hospital Universitario Central de Asturias, 33006 Oviedo, Spain. joseantonio.boga@sespa.princast.es

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|February 26, 2013
PubMed

Insights

Mitochondria are key players in innate antiviral immunity, regulating signaling pathways. The mitochondrial antiviral signaling protein (MAVS) is central to these antiviral and inflammatory responses, with a related patent highlighted.

Area of Science:

  • Mitochondrial biology
  • Immunology
  • Virology

Background:

  • Mitochondria are traditionally known for metabolic roles and apoptosis regulation.
  • Emerging evidence highlights mitochondria as crucial hubs in innate antiviral immunity.
  • The mitochondrial antiviral signaling protein (MAVS) is a key regulator in this context.

Purpose of the Study:

  • To review the emerging role of mitochondria in innate antiviral immunity.
  • To describe the function of the mitochondrial antiviral signaling protein (MAVS) in antiviral responses.
  • To highlight a patent related to MAVS's role in immunity.

Main Methods:

  • Literature review of studies on mitochondria and antiviral immunity.
  • Analysis of MAVS-mediated signaling pathways.
  • Examination of patent literature concerning MAVS.

Main Results:

  • Mitochondria actively participate in innate antiviral immune responses.
  • MAVS acts as a central signaling regulator, initiating antiviral and inflammatory cascades.
  • A patent leveraging MAVS's function in immunity has been identified.

Conclusions:

  • Mitochondria are fundamental to innate antiviral immunity.
  • MAVS is a critical mediator of cellular antiviral defense mechanisms.
  • The therapeutic and patented potential of targeting MAVS in antiviral strategies is significant.

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus11:28

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

Published on: October 7, 2011

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...